278. Huge lymphatic malformation with cervicofacial lesion Clinical trials / Disease details
Clinical trials : 19 / Drugs : 22 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 63
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02335242 (ClinicalTrials.gov) | May 23, 2015 | 7/1/2015 | Sildenafil for the Treatment of Lymphatic Malformations | Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations | Lymphatic Malformations;Lymphatic Diseases | Drug: Sildenafil 20 mg tablets;Other: Placebo tablets (resembling Revatio) | Stanford University | Ann & Robert H Lurie Children's Hospital of Chicago | Active, not recruiting | 6 Months | 10 Years | All | 18 | Phase 2 | United States |
| 2 | ChiCTR-OPC-16008702 | 2014-05-01 | 2016-06-22 | Efficacy and safety of oral sildenafil in the treatment of pediatric lymphatic malformations in China | Sildenafil in the treatment of pediatric lymphatic malformations | pediatric lymphatic malformations | Sildenafil-treated group:oral sildenafil; | Beijing Children's Hospital | NULL | Recruiting | Both | Sildenafil-treated group:40; | China |